Koshinski Asset Management
PJP icon

Koshinski Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Koshinski Asset Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-150
Closed -$11.9K – 1581
2022
Q1 		$11.9K Hold
150
– – ﹤0.01% 1556
2021
Q4 		$12.2K Hold
150
– – ﹤0.01% 1576
2021
Q3 		$11.6K Buy
+150
New +$12.1K ﹤0.01% 1615

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Koshinski Asset Management's PJP Position: Q2 2022 in Review

Koshinski Asset Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2022, closing a stake of 150 shares — an estimated $11.9K sold.

Koshinski Asset Management first reported a position in PJP in Q3 2021 and held it in 3 quarters. The position peaked at $12.2K in Q4 2021. 79 funds tracked by Wall St. Rank hold PJP as of Q2 2022.

  • Koshinski Asset Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 150 Invesco Pharmaceuticals ETF shares in Q2 2022, an estimated $11.9K.
  • Koshinski Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's Invesco Pharmaceuticals ETF position peaked at $12.2K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.